Judge Rufe Archives - Carey Danis & Lowe

Zoloft Birth Defects Lawsuit Update: Latest Developments in Pennsylvania Zoloft MDL

By | Antidepressant, Pharmaceutical litigation, Uncategorized, Zoloft

SSRI Antidpressant Zoloft Birth Defects LitigationThe latest development to come out of the Zoloft birth defects multidistrict litigation (MDL) in the U.S. District Court for the Eastern District of Pennsylvania involves a back and forth between the plaintiffs and the federal judge handling the MDL. Their discussion involves discovery pool and trial pool case selections.

U.S. District Judge Cynthia M. Rufe is presiding over the Zoloft MDL. In late August, she submitted a trial pool selection guideline. In early September, the plaintiffs filed an objection of Judge Rufe’s selection guidelines, taking issue with the defendants’ ability to remove cases from the discovery pool.

The plaintiffs requested that Judge Rufe update her protocol so that the defendants are unable to remove, or strike, cases from the discovery pool submitted by the same plaintiffs’ legal counsel. The plaintiffs made this request on the basis of maintaining a variety of cases in the initial discovery pool, especially as it pertains to the plaintiffs’ legal counsel.

In the court document about this matter, Judge Rufe stated that the selection process for the discovery and trial pools should not involve reference to the plaintiffs’ legal counsel, as this does not necessarily provide a representative case.

The goal in selecting cases for the discovery and trial pools is to find a representative case suitable for a bellwether trial that supports an efficient legal process, and will aid in post-trial settlement.

Ultimately, Judge Rufe came to the conclusion that the defendants cannot remove two cases from the discovery pool whose plaintiffs are represented by the same legal counsel.

Carey Danis & Lowe Zoloft birth defects lawyers are keeping a watchful eye on the Zoloft MDL as it inches closer and closer to the bellwether trial process. Above all, the multidistrict litigation process makes for an efficient legal process. In regards to the most recent court filing in the Zoloft birth defects MDL, Carey Danis & Lowe hopes that the latest ruling is in keeping with this core purpose.

Carey Danis & Lowe is currently accepting Zoloft birth defects cases. Contact Carey Danis & Lowe today for a free legal consultation about your case, and to determine if you and your family are be eligible for compensation. Our Zoloft attorneys can also assist in filing Zoloft birth defects lawsuits.

If you have questions about Zoloft birth defects, voice your questions and concerns to one of our on-staff nurses.

Share your Zoloft birth defects story with Carey Danis & Lowe by calling 800.721.2519, or by submitting a personal injury claim form.

Carey Danis & Lowe Evaluating Zoloft Cases and Offers an Update on Zoloft Lawsuits in Zoloft MDL No. 2342

By | Pharmaceutical litigation, Uncategorized, Zoloft

Published January 14, 2013 by PR Web

St. Louis, Missouri (PRWEB) January 14, 2013

Zoloft MDL Updates: Zoloft MDL No. 2342 Progresses with Order to Submit Initial Discovery Zoloft Birth Defect CasesZoloft lawsuits have been consolidated into a Multi-District Litigation in the U.S. District Court for the Eastern District of Pennsylvania. Judge Cynthia M. Rufe is presiding over the Zoloft MDL.

As to recent developments in the Zoloft MDL, on January 2, 2013, Judge Rufe sent forth Pretrial Order No. 16. Fundamentally, the Pretrial Order outlines how to deliver responses in the MDL. The court document imparts detailed information as to “the procedure for filing responses to all civil actions that are or become consolidated in MDL No. 2342”.*

The Pretrial Order goes on to supply information on how the defendants, Pfizer Inc., Greenstone LLC, and Pfizer International LLC, shall go about filing a Master Short-Form Answer. In essence, the Master-Short Form Answer and Affirmative Defense is the defendants’ response to the claims of the plaintiffs.

According to the Pretrial Order, the Defendants will only have the opportunity to file one Master Short-Form Answer, and in doing so can address any and all charges made against them in each of the cases consolidated in the Zoloft MDL. As the document will stand as their initial response to allegations, Pfizer and Greenstone can deny the plaintiffs’ allegations, and in so doing, they can lay out a defense.

If relying upon information supplied in a recent report, there are quite a number of Zoloft cases in the MDL, and therefore each of these cases will necessitate address in the defense’s response. A Florida attorney who sits on the Plaintiffs’ Steering Committee (PSC), Bryan F. Aylstock, recently submitted a report late last year regarding the status of the Zoloft MDL. The legal journal, The Madison-St. Clair Record, stated that according to information contained in Alystock’s report, there are over 250 cases that have been consolidated into the Zoloft MDL.*

Plaintiffs in the Zoloft MDL have filed lawsuits against Pfizer, the manufacturer of Zoloft, claiming that the antidepressant drug, classified as a selective serotonin re-uptake inhibitor (SSRI), causes birth defects in newborn children when taken by women during pregnancy.

In a separate Zoloft lawsuit being heard in the Wayne County Circuit Court in West Virginia, nineteen plaintiffs, who are the children of mothers who claimed to have taken Zoloft during pregnancy, filed their lawsuit alleging that exposure to Zoloft in the womb resulted in the development of their birth defects.

According to the legal journal, The West Virginia Record, the plaintiffs identified these Zoloft linked birth defects as heart defects, such as atrial septal defects and holes in the heart, persistent pulmonary hypertension of the newborn (PPHN), skull and facial deformations, and a number of other congenital birth defects related to Zoloft exposure in utero.*

Lawyers at Carey Danis & Lowe are currently evaluating Zoloft cases, and they are offering legal consultations to those individuals who claim to have been harmed by the use of Zoloft during pregnancy. For more information about filing a Zoloft lawsuit, and specifically one related to Zoloft and birth defects, contact a lawyer at Carey Danis & Lowe by calling 800-721-2519.